# PENTHROX™ in the Canadian Emergency Department (ED)

> **NCT03868436** · PHASE4 · COMPLETED · sponsor: **Purdue Pharma, Canada** · enrollment: 99 (actual)

## Conditions studied

- Pain, Acute

## Interventions

- **DRUG:** Methoxyflurane 3mL

## Key facts

- **NCT ID:** NCT03868436
- **Lead sponsor:** Purdue Pharma, Canada
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-08
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-09-08
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03868436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03868436, "PENTHROX™ in the Canadian Emergency Department (ED)". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03868436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*